Pfizer

Why Pfizer likely isn't done with M&A after the Seagen deal The Motley Fool10:51
Pfizer has another blockbuster on the horizon, but that's not all The Motley Fool10:06
1 Top healthcare stock that could make you richer in the next decade The Motley Fool09:15
Pfizer stock (NYSE:PFE): Exceptional value near 52-week lows TipRanks20:51
2 Undervalued stocks to buy today to prepare for the next bull market The Motley Fool08:39
Astellas, Pfizer look to broaden Xtandi’s patient base with new prostate cancer win after 8… FiercePharma11:22
Pharma stock roundup: M&A boom in drug industry with PFE & SNY deals, other updates Zacks09:34

Latest News

In the last 4 hours

GSK, eyeing new blockbuster market, taps Magic Johnson to raise RSV awareness ahead of Pfizer… FiercePharma12:23

In the last 6 hours

Why Pfizer Likely Isn't Done With M&A After the Seagen Deal The Motley Fool10:51

US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi FiercePharma10:42

In the last 8 hours

Pfizer-Backed Flare Seeks Transcription Factor Therapies with $123M Series B BioSpace09:46

Pfizer (NYSE:PFE) Will Not Slash Prices for Xtandi TipRanks08:00

Earlier today

BioNTech to produce trial cancer vaccine in Jerusalem Globes07:02

Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing PR Newswire (Press Release)06:34

Egypt receives over 650,000 doses of Pfizer's covid Omicron boosters Ahram Online06:16

Egypt receives second shipment of Pfizer's updated Covid-19 vaccine The National05:18

One year after the first shot, pharma must urgently “share the tech” of COVID-19 vaccines MSF Access Campaign04:34

MSF responds to FDA approval of COVID-19 treatment nirmatrelvir/ritonavir MSF Access Campaign04:13

'Korea may need to spend over $2 trillion annually if Pfizer, Moderna increase Covid-19 vaccine price' Korea Biomedical Review04:10

AION Labs, In Continued Partnership with BioMed X, Launches First 2023 Global Call for Applications: Developing… BioSpace01:37

Yesterday

US declines to force lower price on cancer drug Xtandi Reuters19:49 21-Mar-23

MarketingRx roundup: What could a US TikTok ban mean for pharma? Pfizer, Lilly lead pharma March Madness advertisers ENDPOINTS12:50 21-Mar-23

SARS-CoV-2 Infection May Mean Need For A CD8+ T Cell Response Booster Science 2.012:39 21-Mar-23

Global Acute Respiratory Distress Syndrome Market Report 2023: A $1.831 Billion Market by 2028 Featuring Silence… GlobeNewswire (Press Release)11:17 21-Mar-23

Pfizer Has Another Blockbuster on the Horizon, but That's Not All The Motley Fool10:06 21-Mar-23

Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analysts Business Wire (Press Release)10:00 21-Mar-23

A "boost for Jerusalem": German biottech company to open vaccine manufacturing plant in capital CTech08:12 21-Mar-23

Astellas and Pfizer reveal positive results for Xtandi PharmaTimes07:14 21-Mar-23

Our Ultimate Stock-Pickers’ Top 10 Dividend-Yielding Stocks MorningStar.com06:15 21-Mar-23

Korean researchers develop AI to predict adverse drug reactions with Pfizer's Paxlovid MobiHealthNews03:05 21-Mar-23

Pfizer finds ways for Xeljanz by varying its uses and forms Korea Biomedical Review00:52 21-Mar-23

In the last 7 days

SARS-CoV-2 infection weakens immune-cell response to vaccination Newswise (Press Release)15:30 20-Mar-23

SARS-CoV-2 infection damages the CD8+ T cell response to vaccination News-Medical.Net14:10 20-Mar-23

Raises for Moderna, Pfizer CEOs Highlight Continuing Trend BioSpace10:48 20-Mar-23

Pfizer to buy cancer biotech Seagen for $43 billion Chemistry World Magazine10:41 20-Mar-23

Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study PMLiVE08:55 20-Mar-23

2 Undervalued Stocks to Buy Today to Prepare for the Next Bull Market The Motley Fool08:39 20-Mar-23

Egypt receives first shipment of modified Pfizer vaccine for COVID-19 Ahram Online08:17 20-Mar-23

RSV Vaccines Are Nearly Here, After Decades of False Starts Scientific American08:08 20-Mar-23

Wipro among 2 IT stocks at 52-week lows; here's why The Times of India04:42 20-Mar-23

Reliance Industries, Pfizer among 245 NSE stocks to touch 52-week lows; 26 hit 52-week highs The Financial Express03:44 20-Mar-23

1 Top Healthcare Stock That Could Make You Richer in the Next Decade The Motley Fool09:15 19-Mar-23

SpaceX, Apple, Pfizer among US businesses exploring investment opportunities in Việt Nam Viet Nam News06:58 18-Mar-23

Seagen goes to Pfizer for $43B; Sanofi buys diabetes partner Provention; Crisis averted in SVB demise; and more ENDPOINTS06:11 18-Mar-23

Singapore first country in Southeast Asia to receive new pneumococcal vaccine Channel NewsAsia04:48 18-Mar-23

Singapore first country in Asia to get new pneumococcal vaccine The Straits Times02:07 18-Mar-23

Singapore’s Health Sciences Authority Approves Pfizer’s Pneumococcal 20-Valent Conjugate Vaccine For Adults 18 Years Or … MediaOutReach (Press Release)02:01 18-Mar-23

'S. Korea Donates COVID-19 Vaccines to Thailand' KBS World Radio22:32 17-Mar-23

Pfizer Stock (NYSE:PFE): Exceptional Value Near 52-Week Lows TipRanks20:51 17-Mar-23

Adverse Events Risk in COVID Vaccine Trials Was One in 565, Doctor Tells National Citizen’s Inquiry The Epoch Times19:09 17-Mar-23

Phase III Results Could Boost Pfizer Revenue Ahead Of Xtandi’s Exclusivity Loss Scrip Pharma Intelligence17:28 17-Mar-23

Pfizer recalls over 4 million packages of Nurtec ODT TurnTo23.com, California15:55 17-Mar-23

Pfizer, CDC Withheld Evidence of Myocarditis After COVID Shots, New Documents Reveal Organic Consumers Association14:54 17-Mar-23

Prescription Migraine Drug Packs Recalled Due To Poisoning Risk For Children Health Digest14:03 17-Mar-23

Pfizer Recalls Millions of Doses of Common Migraine Drug The Epoch Times13:44 17-Mar-23

Pfizer’s COVID Pill Paxlovid Inching Closer to Getting FDA Approval The Epoch Times12:59 17-Mar-23

Pfizer Recalls Over 4 Million Products for Scary Reason The Olympian, Washington12:35 17-Mar-23

Pfizer's (PFE) COVID-19 Drug Paxlovid Gets FDA Panel Vote Zacks11:37 17-Mar-23

Pfizer Recalls Millions Of Pills Over Risk Of Child Poisoning The Daily Caller11:27 17-Mar-23

Astellas, Pfizer look to broaden Xtandi’s patient base with new prostate cancer win after 8… FiercePharma11:22 17-Mar-23

The Battle Over the COVID-19 Vaccine Continues JD Supra11:00 17-Mar-23

Pfizer's Bourla and Moderna's Bancel saw compensation bumps in 2022 ENDPOINTS10:51 17-Mar-23

Pfizer and Astellas Seek Expanded Label for Expensive Prostate Cancer Drug BioSpace10:00 17-Mar-23

Pharma Stock Roundup: M&A Boom in Drug Industry With PFE & SNY Deals, Other Updates Zacks09:34 17-Mar-23

Pizer recalls 4.2 million tablets of Nurtec ODT prescription drugs ConsumerAffairs.Com09:24 17-Mar-23

Is Pfizer Stock Undervalued At $40? Forbes09:07 17-Mar-23

Better RSV Vaccine Stock: Pfizer, GSK, or Moderna? The Motley Fool08:54 17-Mar-23

Pfizer's Paxlovid gets thumbs-up for full approval from FDA advisory committee FiercePharma08:29 17-Mar-23

Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray PMLiVE07:52 17-Mar-23

Pfizer, Astellas tout positive PhIII data to potentially expand Xtandi label ENDPOINTS07:28 17-Mar-23

Pfizer recalls millions of migraine prescription drug packs due to a risk of child poisoning NBC News07:13 17-Mar-23

Lessons From The Pandemic: A Q&A With Pfizer’s Former CFO Forbes07:09 17-Mar-23

Pigmentation Disorders Treatment Market Report (2022 to 2030) - Pfizer Inc., Candela Corporation, L'Oréal SA, Healio… GlobeNewswire (Press Release)02:44 17-Mar-23

Pfizer Recall: 4.2 Million Units Of Prescription Drug Pulled Over Poisoning Risk International Business Times - AU Edition23:07 16-Mar-23

Pfizer Recall: 4.2 Million Packs Of Drug Pulled Over Poisoning Risk IBTimes (US)22:07 16-Mar-23

Pfizer’s Paxlovid Antiviral Gets FDA Panel’s Nod for Full Approval BNN Bloomberg19:46 16-Mar-23

Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves… PR Newswire (Press Release)19:35 16-Mar-23

Advisory panel recommends full FDA approval for COVID-19 medication Paxlovid UPI19:02 16-Mar-23

Pfizer recalls 4.2million drug packets due to risk of child poisoning Mail Online18:34 16-Mar-23

FDA advisers vote in favor of full approval for Pfizer's COVID pill Paxlovid Fox News18:33 16-Mar-23

Google, Pfizer, Chobani And Other Major Companies Pledge To Pair Afghan Refugees With Military Veterans As Mentors Forbes18:16 16-Mar-23

Pfizer recalls millions of packages of prescription drugs due to risk of poisoning CBS Austin17:56 16-Mar-23

At Fifteen Months Post-Launch, AbbVie's Qulipta Outperforms Pfizer's Nurtec ODT on Perceived… PR Newswire (Press Release)17:56 16-Mar-23

Paxlovid Moves Closer to Full FDA Approval TIME17:38 16-Mar-23

What Seagen’s Pipeline Will Bring To Pfizer Scrip Pharma Intelligence17:31 16-Mar-23

Covid-19 pill Paxlovid moves closer to full FDA approval ABC News16:40 16-Mar-23

FDA adcomm votes in favor of Pfizer's Covid-19 pill Paxlovid ENDPOINTS16:33 16-Mar-23

FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk… CNBC15:38 16-Mar-23

FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer’s PAXLOVID™ Business Wire (Press Release)15:24 16-Mar-23

FDA committee says benefits outweigh risks for Pfizer’s Paxlovid MarketWatch15:22 16-Mar-23

U.S. FDA advisers vote in favor of full approval for Pfizer's COVID pill Paxlovid Reuters14:36 16-Mar-23

Pfizer ‘recalls’ 4.2 million boxes of Nurtec migraine medicine due to lack of childproofing The Washington Times14:21 16-Mar-23

Pfizer seeks to ease concerns after US consumer group flags Nurtec recall FiercePharma11:40 16-Mar-23

Pfizer the biggest TV drug ad spender at the Oscars, as HHS also spends big on COVID messaging FiercePharma11:29 16-Mar-23

Plan to phase out Pfizer-BioNTech COVID-19 vaccine halted Focus Taiwan11:11 16-Mar-23

Major Companies Pledge to Help Afghan Refugees Advance Their Careers with Support of U.S.… PR Newswire (Press Release)11:05 16-Mar-23

Global Therapeutic Proteins Market Report 2023: Featuring Abbott Laboratories, Amgen, Baxter International and Pfizer… GlobeNewswire (Press Release)10:08 16-Mar-23

Pfizer recalls migraine drug over packaging issues - CPSC Reuters10:05 16-Mar-23

This Must-Buy Dividend Growth Stock Could Pay You for Life The Motley Fool10:00 16-Mar-23

FDA says Pfizer COVID pill EUA for adolescents to stay even after nod for adults Reuters09:38 16-Mar-23

Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging… U.S. Consumer Product Safety Commission (Press Release)09:21 16-Mar-23

Pfizer Executive on Supply Chain: 'One Country Cannot Solve It All' HealthLeaders09:16 16-Mar-23

LIVE NOW: FDA Advisers Meet to Discuss Pfizer’s CO NTD News08:57 16-Mar-23

Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors GlobeNewswire (Press Release)07:32 16-Mar-23

Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK ENDPOINTS07:03 16-Mar-23

One Month to More Effective Compliance for Business Ventures - Day 12 - Post Acquisition Integration JD Supra06:47 16-Mar-23

Africa: Malawi, Rwanda and Zambia Receive Covid-19 Treatments for High-Risk Patients AllAfrica06:21 16-Mar-23

Here's Why Pfizer Stock Is Looking Increasingly Attractive The Motley Fool05:56 16-Mar-23

Pfizer/BioNTech COVID-19 vaccine available again for individuals under 18 as their first dose; those who have not… Taiwan Centers for Disease Control (Press Release)04:56 16-Mar-23

Pfizer Korea doubles its annual sales in 2022 Korea Biomedical Review02:40 16-Mar-23

Pfizer CEO Backed Mehmet Oz; Trouble Filling NIH Top Job; AI Denies Seniors Care Medpage Today02:30 16-Mar-23

KAIST's AI-backed platform predicts drug-drug interactions using Pfizer’s Paxlovid Korea Biomedical Review02:03 16-Mar-23

COVID vaccine update: FDA authorizes Pfizer booster for some children under age five Fox News17:00 15-Mar-23

FDA panel to consider full approval of Pfizer's COVID-19 drug Paxlovid UPI15:34 15-Mar-23

Pfizer (PFE) Gets FDA Nod for Bivalent COVID Jab in Infants Zacks14:07 15-Mar-23

In Pfizer-Seagen review, FTC has chance to set new pharma precedent BioPharma Dive13:59 15-Mar-23

Paxlovid is safe, effective and doesn’t cause ‘rebound,’ FDA says The Hill12:33 15-Mar-23

FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine As Booster Dose For Young Children Drug Topics12:11 15-Mar-23

Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock Entrepreneur Magazine12:00 15-Mar-23

Royalty Pharma raises FY2023 guidance after $475M Pfizer milestone payment Proactive Investors (US)11:49 15-Mar-23

How well do first and second vaccine doses work against Covid-19? Wellcome11:49 15-Mar-23

Emails Show Journal’s Discussion Before Rejecting Paper Challenging Pfizer’s Claim of 95 Percent Vaccine Effectiveness The Epoch Times11:35 15-Mar-23

view more headlines

22 Mar 12:23

Pfizer News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Pfizer news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. N.B. Relevance is automatically assessed so some headlines not qualifying as Pfizer news might appear - please feel free to contact us regarding any persistent issues.

Pfizer

Latest News

Pfizer News

Pharmaceuticals Top Stories

Business Top Stories